NasdaqCM - Nasdaq Real Time Price • USD
Enlivex Therapeutics Ltd. (ENLV)
At close: April 25 at 4:00 PM EDT
After hours: April 25 at 7:01 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-23,064.0000
-23,953.0000
-17,542.0000
-11,007.0000
Investing Cash Flow
-32,979.0000
62,524.0000
-38,408.0000
-20,977.0000
Financing Cash Flow
360.0000
150.0000
60,982.0000
33,082.0000
End Cash Position
2,368.0000
50,357.0000
11,636.0000
7,012.0000
Capital Expenditure
-2,810.0000
-8,122.0000
-1,625.0000
-1,019.0000
Issuance of Capital Stock
360.0000
--
53,174.0000
24,467.0000
Free Cash Flow
-25,874.0000
-32,075.0000
-19,167.0000
-12,026.0000
12/31/2020 - 7/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BLRX BioLineRx Ltd.
0.5753
-6.15%
EVGN Evogene Ltd.
0.6587
-1.61%
PLUR Pluri Inc.
4.9000
-3.73%
CANF Can-Fite BioPharma Ltd.
1.9200
-1.03%
ORMP Oramed Pharmaceuticals Inc.
2.3000
-2.95%
CGEN Compugen Ltd.
1.9000
-0.52%
MDWD MediWound Ltd.
17.66
+0.40%
XTLB XTL Biopharmaceuticals Ltd.
2.4000
-6.25%
QNRX Quoin Pharmaceuticals, Ltd.
0.6300
-1.95%
LCTX Lineage Cell Therapeutics, Inc.
1.1100
+0.91%